OrbiMed raises two new life sciences funds worth $3B with one aiming for Asia
The sixth cycle of OrbiMed’s Asia Partners fund included one with more than $1 billion earmarked for life science companies based on the Eastern continent.
OrbiMed raises two new life sciences funds worth $3B with one aiming for Asia Read More »
